Jafron Biomedical Co.,Ltd.’s Net Profit Rose 20.5% in First Half of 2022

Jafron Biomedical Co.,Ltd. (健帆生物科技集团股份有限公司) (300529.SZ) reported a net profit of 746 million yuan in the first half of 2022, up 20.5% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 30.8% year-on-year.

At the end of the reporting period, it had 4.9 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 29.6%.